One of the most studied fusion proteins is the Philadelphia chromosome translocation, which creates the BCR-ABL fusion protein. Other examples include the EML4-ALK fusion in non-small cell lung cancer and the TMPRSS2-ERG fusion in prostate cancer. These fusion proteins are often specific to certain cancer types, making them valuable diagnostic markers and potential therapeutic targets.